Vimarsana
Biggest News Aggregation in the World

Page 2 - Deborah Sheldon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deborah Sheldon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deborah Sheldon Today - Breaking & Trending Today

False Claims Act Issues Go to Supreme Court in 2022 - Vimarsana News

False Claims Act Issues Go to Supreme Court in 2022

False Claims Act FCA cases have garnered significant attention. Two of those questions ultimately made their way to the Supreme Court. Court addresses whether the government has authority to dismiss an FCA case brought by a private citizen on the government’s behalf.

SCOTUS To Hear Second False Claims Act Issue This Term - Vimarsana News

SCOTUS To Hear Second False Claims Act Issue This Term

Supreme Court agreed to hear a second False Claims Act FCA issue this term previously accepted and heard argument on a case concerning government’s authority to dismiss an FCA whistleblower case after declining to intervene. U.S. ex rel. Tracy Schutte v. SuperValu case.

Review: Wilder by Millie Kerr - Vimarsana News

Review: Wilder by Millie Kerr

Journalist and former lawyer Millie Kerr explores the beauty and challenge of rewilding in this compelling and occasionally personal book

Pharma Manufacturer Federal Government Price Reporting: Recent Litigation And Settlements - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Pharma Manufacturer Federal Government Price Reporting: Recent Litigation And Settlements - Life Sciences, Biotechnology & Nanotechnology

Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP)1 has been very active in 2022. Most recently, on August 3, 2022, an Illinois federal jury...

Source: mondaq.com
Pharma Manufacturer Federal Government Price Reporting: Recent Litigation and Settlements | Goodwin - Vimarsana News

Pharma Manufacturer Federal Government Price Reporting: Recent Litigation and Settlements | Goodwin

​​​​​​​Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP)  has been very active in 2022. Most recently, on August 3, 2022, an Illinois federal jury...